IBDEI0K7 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9837,0)
 ;;=366.9^^58^645^22
 ;;^UTILITY(U,$J,358.3,9837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9837,1,4,0)
 ;;=4^366.9
 ;;^UTILITY(U,$J,358.3,9837,1,5,0)
 ;;=5^CATARACT NOS
 ;;^UTILITY(U,$J,358.3,9838,0)
 ;;=278.00^^58^645^81
 ;;^UTILITY(U,$J,358.3,9838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9838,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,9838,1,5,0)
 ;;=5^OBESITY, UNSP
 ;;^UTILITY(U,$J,358.3,9839,0)
 ;;=365.9^^58^645^56
 ;;^UTILITY(U,$J,358.3,9839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9839,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,9839,1,5,0)
 ;;=5^GLAUCOMA NOS
 ;;^UTILITY(U,$J,358.3,9840,0)
 ;;=496.^^58^645^39
 ;;^UTILITY(U,$J,358.3,9840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9840,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,9840,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,9841,0)
 ;;=437.9^^58^645^23
 ;;^UTILITY(U,$J,358.3,9841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9841,1,4,0)
 ;;=4^437.9
 ;;^UTILITY(U,$J,358.3,9841,1,5,0)
 ;;=5^CEREBROVASC DISEASE NOS
 ;;^UTILITY(U,$J,358.3,9842,0)
 ;;=780.4^^58^645^45
 ;;^UTILITY(U,$J,358.3,9842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9842,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,9842,1,5,0)
 ;;=5^DIZZINESS AND GIDDINESS
 ;;^UTILITY(U,$J,358.3,9843,0)
 ;;=332.0^^58^645^84
 ;;^UTILITY(U,$J,358.3,9843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9843,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,9843,1,5,0)
 ;;=5^PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,9844,0)
 ;;=356.9^^58^645^87
 ;;^UTILITY(U,$J,358.3,9844,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9844,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,9844,1,5,0)
 ;;=5^PERIPHERAL NEUROPATHY
 ;;^UTILITY(U,$J,358.3,9845,0)
 ;;=786.2^^58^645^40
 ;;^UTILITY(U,$J,358.3,9845,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9845,1,4,0)
 ;;=4^786.2
 ;;^UTILITY(U,$J,358.3,9845,1,5,0)
 ;;=5^COUGH
 ;;^UTILITY(U,$J,358.3,9846,0)
 ;;=435.9^^58^645^97
 ;;^UTILITY(U,$J,358.3,9846,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9846,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,9846,1,5,0)
 ;;=5^TRANS CEREB ISCHEMIA NOS
 ;;^UTILITY(U,$J,358.3,9847,0)
 ;;=518.89^^58^645^91
 ;;^UTILITY(U,$J,358.3,9847,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9847,1,4,0)
 ;;=4^518.89
 ;;^UTILITY(U,$J,358.3,9847,1,5,0)
 ;;=5^PULMONARY NODULE
 ;;^UTILITY(U,$J,358.3,9848,0)
 ;;=784.0^^58^645^58
 ;;^UTILITY(U,$J,358.3,9848,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9848,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,9848,1,5,0)
 ;;=5^HEADACHE
 ;;^UTILITY(U,$J,358.3,9849,0)
 ;;=477.9^^58^645^2
 ;;^UTILITY(U,$J,358.3,9849,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9849,1,4,0)
 ;;=4^477.9
 ;;^UTILITY(U,$J,358.3,9849,1,5,0)
 ;;=5^ALLERGIC RHINITIS NOS
 ;;^UTILITY(U,$J,358.3,9850,0)
 ;;=465.9^^58^645^99
 ;;^UTILITY(U,$J,358.3,9850,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9850,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,9850,1,5,0)
 ;;=5^URI, ACUTE
 ;;^UTILITY(U,$J,358.3,9851,0)
 ;;=473.9^^58^645^93
 ;;^UTILITY(U,$J,358.3,9851,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9851,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,9851,1,5,0)
 ;;=5^SINUSITIS, CHRONIC
 ;;^UTILITY(U,$J,358.3,9852,0)
 ;;=536.8^^58^645^47
 ;;^UTILITY(U,$J,358.3,9852,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9852,1,4,0)
 ;;=4^536.8
 ;;^UTILITY(U,$J,358.3,9852,1,5,0)
 ;;=5^DYSPEPSIA
 ;;^UTILITY(U,$J,358.3,9853,0)
 ;;=786.09^^58^645^51
 ;;^UTILITY(U,$J,358.3,9853,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9853,1,4,0)
 ;;=4^786.09
 ;;^UTILITY(U,$J,358.3,9853,1,5,0)
 ;;=5^DYSPNEA
 ;;^UTILITY(U,$J,358.3,9854,0)
 ;;=530.9^^58^645^53
 ;;^UTILITY(U,$J,358.3,9854,1,0)
 ;;=^358.31IA^5^2
